跳转至内容
Merck
CN
  • Metabolic stability of new anticonvulsants in body fluids and organ homogenates.

Metabolic stability of new anticonvulsants in body fluids and organ homogenates.

Acta poloniae pharmaceutica (2012-05-12)
Dorota Marszałek, Anna Goldnik, Franciszek Pluciński, Aleksander P Mazurek, Anna Jakubiak, Ewa Lis, Piotr Tazbir, Agnieszka Koziorowska
摘要

The stability as a function of time of compounds with established anticonvulsant activity: picolinic acid benzylamide (Pic-BZA), picolinic acid 2-fluorobenzylamide (Pic-2-F-BZA), picolinic acid 3-fluorobenzylamide (Pic-3-F-BZA), picolinic acid 4-fluorobenzylamide (Pic-4-F-BZA) and picolinic acid 2-methylbenzylamide (Pic-2-Me-BZA) in body fluids and homogenates of body organs were determined after incubation. It was found that they decompose relatively rapidly in liver and kidney and are stable against enzymes present in body fluids and some organs. These results are consistent with the bond strength expressed as total energy of amide bonds (calculated by quantum chemical methods) in the studied anticonvulsants. The calculated values of the amide bond energy are: 199.4 kcal/mol, 200.2 kcal/mol, 207.5 kcal/mol, 208.4 kcal/mol and 198.2 kcal/mol, respectively. The strength of the amide bonds in the studied anticonvulsants correctly reflects their stability in liver or kidney.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
2-吡啶甲酸, ReagentPlus®, 99%